Updates are available Correction dated 2025-08-05
Click to view Correction: https://doi.org/10.1038/s43587-025-00949-4
-
Authors
Alvarez-Kuglen, Martin https://orcid.org/0009-0002-8197-4538
Ninomiya, Kenta https://orcid.org/0000-0002-9566-4875
Qin, Haodong
Rodriguez, Delany
Fiengo, Lorenzo
Farhy, Chen
Hsu, Wei-Mien
Kirk, Brian
Havas, Aaron https://orcid.org/0000-0003-4291-8015
Kaufman, Collin
Feng, Gen-Sheng
Roberts, Amanda J.
Anderson, Rozalyn M. https://orcid.org/0000-0002-0864-7998
Serrano, Manuel https://orcid.org/0000-0001-7177-9312
Adams, Peter D. https://orcid.org/0000-0002-0684-1770
Sharpee, Tatyana O.
Terskikh, Alexey V. https://orcid.org/0000-0003-4641-3997
-
Funding
Funding for this research was provided by:
National Institute of Aging
- License Information
-
More Information
Article History
Received: 23 October 2023
Accepted: 11 July 2024
First Online: 29 August 2024
Change Date: 29 November 2024
Change Type: Update
Change Details: In the version of the article initially published, Alexey V. Terskikh’s second affiliation (Harry Perkins Institute of Medical Research, The University of Western Australia, Perth, Western Australia, Australia) was not labelled as a present address. This has now been corrected in the HTML and PDF versions of the article.
Change Date: 5 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s43587-025-00949-4
Competing interests
: L.F. is currently an employee of Bristol Myers Squibb; W.-M.H. is currently an employee of Ingram Micro; B.K. is currently an employee of Zafrens; M.S. is an employee of Altos Labs and shareholder of Altos Labs, Life Biosiences, Senolytic Therapeutics and Rejuveron Senescence Therapeutics; A.V.T. is a shareholder of Stemson Therapeutics. The other authors declare no competing interests.
